10.1016/j.jacc.2007.10.001
10.1016/j.jacc.2006.12.050
10.1016/j.jacc.2007.01.003
10.1016/S0140-6736(08)60922-8
10.1161/circulationaha.106.181424
10.1161/circulationaha.105.568451
10.1053/j.gastro.2005.08.003
10.1111/j.1572-0241.2006.00723.x
10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V
10.1016/S0889-8553(05)70247-8
10.1001/archinte.164.11.1243
10.1111/j.1365-2036.2007.03292.x
10.1056/NEJM200011233432103
10.7326/0003-4819-109-5-359
10.7326/0003-4819-114-4-257
10.1093/oxfordjournals.aje.a117469
Hawkey CJ, Talley NJ, Scheiman JM, et al. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Res Ther. 9: 2007; R17.
Ofman JJ, MacLean CH, Straus WL, et al. A meta-analysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol. 29: 2002; 804–12.
Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol Suppl. 56: 1999; 18–24.
10.1111/j.1365-2036.2008.03706.x
10.1136/bmj.38947.697558.AE
Johnson DA. Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist. Rev Cardiovasc Med. 6 2005; (suppl 4): S15–22.
10.1111/j.1572-0241.2007.01595.x
10.1056/NEJM200009213431202
10.1016/S0140-6736(07)60722-3
10.1161/01.cir.0000020190.45892.75
10.1161/circulationaha.107.181546
10.7326/0003-4819-136-2-200201150-00016
10.1111/j.1365-2036.2004.01935.x
10.1111/j.1365-2036.2005.02649.x
10.1016/S0140-6736(96)01254-8
10.1016/j.amjmed.2005.10.039
10.1111/j.1572-0241.2000.02248.x
10.1001/archinte.1994.00420010064008
10.1136/bmj.321.7270.1183
Laine L, McQuaid K. Bleeding complications related to aspirin dose. Am J Cardiol. 96: 2005; 1035–6.
10.1016/j.amjcard.2005.01.049
10.1161/01.cir.0000091201.39590.cb
10.1046/j.0306-5251.2001.01476.x
10.1161/CIRCULATIONAHA.107.729558
10.1016/j.jacc.2007.10.002
10.1111/j.1538-7836.2007.02499.x
10.1097/00042737-200302000-00011
10.1111/j.1365-2036.2005.02560.x
10.1016/S0140-6736(96)91270-2
10.1016/S0140-6736(96)09457-3
10.1001/archinte.164.14.1490
10.1161/circulationaha.106.180944
10.1016/S0140-6736(04)16721-4
10.1161/circulationaha.107.719484
10.1097/00004836-200205000-00009
10.1080/003655200750023705
10.1016/j.cgh.2006.04.019
10.1111/j.1572-0241.2006.01062.x
Khurram Z, Chou E, Minutello R, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol. 18: 2006; 162–4.
10.1046/j.1365-2036.2000.00739.x
10.1016/j.clinthera.2004.10.002
10.7326/0003-4819-123-4-199508150-00001
10.1111/j.1365-2125.1989.tb03545.x
10.1111/j.1365-2036.1992.tb00735.x
10.1111/j.1572-0241.2007.01460.x
10.1056/NEJM200103293441304
10.1080/00365520310003967
10.1111/j.1572-0241.2006.00499.x
10.1016/j.jacc.2007.06.064
10.1016/j.jacc.2007.12.056
10.1046/j.1365-2036.2002.01230.x
10.1046/j.1365-2036.2002.01197.x
Chan FK. Long-term incidence of ulcer bleeding with low-dose aspirin after eradication of H pylori: a 4-year prospective cohort study (abstr). Gastroenterology. 128: 2005; A133.
10.1111/j.1572-0241.2007.01393.x
Dorward S, Sreedharan A, Leontiadis GI, Howden CW, Moayyedi P, Forman D. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2006; CD005415.
10.1016/0016-5085(78)90352-9
Sung J, Lau J, Ching J, et al. Can aspirin be reintroduced with PPI inhibitor INFUSION after endoscopic hemostatis: a double-blinded randomized controlled trial (abstr). Gastroenterology. 130: 2008; A44.
10.1016/S0016-5107(02)70402-1
